This inventor holds 1 USPTO granted patent. Top assignee: Symbicom Aktiebolag. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Jan Tornell - Innovator in Human Milk Protein Research
Introduction
Jan Tornell is a notable inventor based in Goteborg, Sweden. He has made significant contributions to the field of biotechnology, particularly in the area of human milk proteins. His work focuses on enhancing the nutritional value of infant formulae through innovative processes.
Latest Patents
Jan Tornell holds a patent for "Human .beta.-casein, process for producing it and use thereof." This invention relates to a DNA sequence encoding the human milk protein .beta.-casein or its analogues, which possess various beneficial activities. The patent outlines a method for producing recombinant human .beta.-casein, particularly through transgenic non-human mammals, such as bovine species. The primary application of this recombinant protein is in infant formulae, where it aims to improve the nutritional and biological value by closely resembling human milk.
Career Highlights
Throughout his career, Jan Tornell has been associated with Symbicom Aktiebolag, where he has contributed to groundbreaking research in the field of milk proteins. His innovative approach has paved the way for advancements in infant nutrition, making a significant impact on the industry.
Collaborations
Jan Tornell has worked alongside esteemed colleagues such as Sven Bergstrom and Olle Hernell. Their collaborative efforts have furthered research and development in the field of biotechnology, particularly in the production of human milk proteins.
Conclusion
Jan Tornell's contributions to the field of human milk protein research highlight his innovative spirit and dedication to improving infant nutrition. His patent for recombinant human .beta.-casein represents a significant advancement in the industry, showcasing the potential of biotechnology in enhancing the quality of infant formulae.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile